TraumaCad App

Register to receive a free US Market for Large Bone & Joint Orthopedic Devices report synopsis and brochure

Medical software developer Voyant Health, a subsidiary of Brainlab, recently received FDA approval for TraumaCad, their orthopedic preoperative surgical planning mobile app. The app is designed to aid orthopedic surgeons in planning for operations like total hip replacement surgery.

The app can automatically align implants and other necessary devices, calculate relevant distances and make proper offsets. It maintains proper calibration based on the patient and comes equipped with templates for different artificial hip types. The app runs on HTML5 enabled web browsers or on an iPad as a standalone iOS app.

“For over a decade, thousands of orthopedic surgeons have been using our TraumaCad technology to plan surgery. In the past several years, mobile devices have transformed how surgeons and health care professionals work by enhancing data access and productivity,” Marc Mackey, general manager of orthopedics at Brainlab, said in the release. “With the mobile version of TraumaCad, digital templating can now be accessed from any web browser or iPad, enabling surgeons to be more productive while also providing access to data for better inventory management.”

About Brainlab
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to and consistency of advanced, less invasive patient treatment. Brainlab technology currently powers treatments in the fields of neurosurgery, orthopedics, ENT, CMF, spine, trauma and radiation therapy. Privately held since its formation in 1989, Brainlab has more than 5,000 systems installed in about 95 countries. To learn more about Brainlab, visit

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook:
Follow us on LinkedIn:
Follow us on Twitter: